{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:47:11Z","timestamp":1792590431598,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.euo.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:59:17Z","timestamp":1685642357000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Martina","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zein Mersini","family":"Besharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Laschena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Trocchianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Splendiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sciarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-918X","authenticated-orcid":false,"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.05.008_b0005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.eururo.2020.12.010","article-title":"Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European Union and the European Commission","volume":"79","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0015","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/biomedicines9101470","article-title":"Network analysis integrating microRNA expression profiling with MRI biomarkers and clinical data for prostate cancer early detection: a proof of concept study","volume":"9","author":"Panebianco","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.euo.2023.05.008_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41540-020-0133-0","article-title":"Prostate cancer screening research can benefit from network medicine: an emerging awareness","volume":"6","author":"Panebianco","year":"2020","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.euo.2023.05.008_b0025","doi-asserted-by":"crossref","first-page":"25602","DOI":"10.1038\/srep25602","article-title":"miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2023.05.008_b0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jnci\/djz112","article-title":"Temporal stability and prognostic biomarker potential of the prostate cancer urine miRNA transcriptome","volume":"112","author":"Jeon","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2023.05.008_b0035","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1158\/1078-0432.CCR-15-0217","article-title":"miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate cancer","volume":"21","author":"Cai","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2023.05.008_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12967-015-0650-6","article-title":"MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells","volume":"13","author":"Wu","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.euo.2023.05.008_b0045","doi-asserted-by":"crossref","first-page":"e20180330","DOI":"10.1590\/1678-4685-gmb-2018-0330","article-title":"Expression of miR-148b-3p is correlated with overexpression of biomarkers in prostate cancer","volume":"43","author":"Ar\u00e1mbula-Meraz","year":"2020","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.euo.2023.05.008_b0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.celrep.2014.06.064","article-title":"Characterization of dual PTEN and p53-targeting MicroRNAs identifies microRNA-638\/Dnm2 as a two-hit oncogenic locus","volume":"8","author":"Tay","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.euo.2023.05.008_b0055","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1677\/ERC-09-0184","article-title":"The role of let-7 in cell differentiation and cancer","volume":"17","author":"Boyerinas","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"76","key":"10.1016\/j.euo.2023.05.008_b0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"2019","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0065","article-title":"EAU guidelines: prostate cancer","author":"Mottet","year":"2021","journal-title":"EAU"},{"key":"10.1016\/j.euo.2023.05.008_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.euo.2023.05.008_b0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2023.05.008_b0080","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.euo.2023.05.008_b0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14640","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"123","author":"Assel","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.05.008_b0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.euo.2023.05.008_b0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","article-title":"Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2023.05.008_b0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.euo.2023.05.008_b0105","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/onc.2017.240","article-title":"miR-302\/367\/LATS2\/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.euo.2023.05.008_b0110","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2023.05.008_b0115","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: a guide for investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0120","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00330-021-08407-6","article-title":"Risk-based MRI-directed diagnostic pathway outperforms non-risk-based pathways in suspected prostate cancer biopsy-na\u00efve men: a large cohort validation study","volume":"32","author":"Bittencourt","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2023.05.008_b0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.21037\/atm.2018.07.02","article-title":"Decision curve analysis: a technical note","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.euo.2023.05.008_b0130","first-page":"221","article-title":"The use of biomarkers in prostate cancer screening and treatment","volume":"19","author":"Alford","year":"2017","journal-title":"Rev Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.euf.2022.06.009","article-title":"Prognostic role of RNA expression molecular biomarkers in prostate and bladder cancers","volume":"8","author":"Ahmed","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.05.008_b0140","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00259-014-2982-5","article-title":"Imaging biomarkers in prostate cancer: role of PET\/CT and MRI","volume":"42","author":"Picchio","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2023.05.008_b0145","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3390\/cancers12102994","article-title":"Systematic review and meta-analysis of Vesical Imaging-Reporting and Data System (VI-RADS) inter-observer reliability: an added value for muscle invasive bladder cancer detection","volume":"12","author":"Del Giudice","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2023.05.008_b0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.juro.2014.07.010","article-title":"Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer","volume":"193","author":"Syring","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0155","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/cncr.31062","article-title":"Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer: circulating miRNAs of colorectal cancer","volume":"124","author":"Zhang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2023.05.008_b0160","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2217\/bmm-2018-0132","article-title":"Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure","volume":"12","author":"Li","year":"2018","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.euo.2023.05.008_b0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.eururo.2019.05.013","article-title":"The state of the science on prostate cancer biomarkers: the San Francisco Consensus statement","volume":"76","author":"Cooperberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0175","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","article-title":"ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training","volume":"30","author":"de Rooij","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2023.05.008_b0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2020.06.023","article-title":"Focus on the quality of prostate multiparametric magnetic resonance imaging: synopsis of the ESUR\/ESUI recommendations on quality assessment and interpretation of images and radiologists\u2019 training","volume":"78","author":"de Rooij","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.05.008_b0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/JU.0000000000001361","article-title":"Clinical utility of 4Kscore\u00ae, ExosomeDx\u2122 and magnetic resonance imaging for the early detection of high grade prostate cancer","volume":"205","author":"de la Calle","year":"2021","journal-title":"J Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:49:39Z","timestamp":1762876179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2588931123001086"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.05.008","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}